TNF and cervical carcinoma: Valproic acid (VPA) exhibits time-dependent inhibition of HIF-1α, VEGF, and tumor necrosis factor (TNF) expression in cervical cancer cells through suppression of PI3K/Akt and ERK1/2 signaling pathways.